AB0615 PREVALENCE OF DEPRESSION, ANXIETY, FATIGUE AND SLEEP DISTURBANCES IN PATIENTS OF RA, SLE AND GPA. (June 2019)
- Record Type:
- Journal Article
- Title:
- AB0615 PREVALENCE OF DEPRESSION, ANXIETY, FATIGUE AND SLEEP DISTURBANCES IN PATIENTS OF RA, SLE AND GPA. (June 2019)
- Main Title:
- AB0615 PREVALENCE OF DEPRESSION, ANXIETY, FATIGUE AND SLEEP DISTURBANCES IN PATIENTS OF RA, SLE AND GPA
- Authors:
- AMAN, SHARMA
Shrivastava, Abhinav
Grover, Sandeep
Jha, Saket
Naidu, Gsrsnk
Rathi, Manish
Jain, Sanjay - Abstract:
- Abstract : Background: The relative frequencies of co-morbidities like depression, anxiety, fatigue and sleep disturbance in RA, SLE and GPA are not fully elucidated. Objectives: To estimate and correlate the prevalence of depression, anxiety, fatigue and sleep disturbances in patients with RA, SLE and GPA by using time honored scales and PROMIS-HAQ 1 . Methods: This was a cross sectional study of 183 patients (RA – 57, SLE – 64, GPA – 62). Diagnosis and assessment of depression, insomnia, anxiety and fatigue was established by patient health questionnaire 9 (PHQ 9), Epworth sleepiness scale (ESS), generalized anxiety disorder assessment scale 7 (GAD 7) and fatigue severity scale (FSS) respectively. PROMIS-HAQ short form 8a was also used to diagnose depression, insomnia, anxiety and fatigue and its correlation with the above time honored scales was studied. Results: Mean age of RA, SLE and GPA patients was 45.5 ± 12, 31 ± 9.5 and 42.7 ± 13.5 years respectively. Mean disease duration was 5.7 ± 5.1, 3.3 ± 2.4 and 4.6 ± 4 years in RA, SLE and GPA respectively. Prevalence of depression, anxiety, fatigue, insomnia in RA, SLE and GPA as per standard scales and PROMIS HAQ is depicted in table 1 . The corelation between the standard scales and PROMIS HAQ for depression [RA (r- .816, p< .001), SLE (r- 0.625, p< 0.001), GPA (r-0.772, p <0.001)], anxiety [RA (r- .804, P< .001), SLE (r- 0.709, p<0.001), GPA (0.888, p<0.001)], sleep disturbance [RA (r- .872, p<0.001), SLE (r- 0.784, p<Abstract : Background: The relative frequencies of co-morbidities like depression, anxiety, fatigue and sleep disturbance in RA, SLE and GPA are not fully elucidated. Objectives: To estimate and correlate the prevalence of depression, anxiety, fatigue and sleep disturbances in patients with RA, SLE and GPA by using time honored scales and PROMIS-HAQ 1 . Methods: This was a cross sectional study of 183 patients (RA – 57, SLE – 64, GPA – 62). Diagnosis and assessment of depression, insomnia, anxiety and fatigue was established by patient health questionnaire 9 (PHQ 9), Epworth sleepiness scale (ESS), generalized anxiety disorder assessment scale 7 (GAD 7) and fatigue severity scale (FSS) respectively. PROMIS-HAQ short form 8a was also used to diagnose depression, insomnia, anxiety and fatigue and its correlation with the above time honored scales was studied. Results: Mean age of RA, SLE and GPA patients was 45.5 ± 12, 31 ± 9.5 and 42.7 ± 13.5 years respectively. Mean disease duration was 5.7 ± 5.1, 3.3 ± 2.4 and 4.6 ± 4 years in RA, SLE and GPA respectively. Prevalence of depression, anxiety, fatigue, insomnia in RA, SLE and GPA as per standard scales and PROMIS HAQ is depicted in table 1 . The corelation between the standard scales and PROMIS HAQ for depression [RA (r- .816, p< .001), SLE (r- 0.625, p< 0.001), GPA (r-0.772, p <0.001)], anxiety [RA (r- .804, P< .001), SLE (r- 0.709, p<0.001), GPA (0.888, p<0.001)], sleep disturbance [RA (r- .872, p<0.001), SLE (r- 0.784, p< 0.001), GPA (r-0.917, p <0.001)] and fatigue [RA (r- .815, p< .001), SLE (r- 0.798, p< 0.001), GPA (r-0.805, p <0.001)] was significant. Conclusion: Depression, anxiety, fatigue and sleep disturbance are common in RA, SLE and GPA. PROMIS HAQ has good correlation with time honoured scales for assesment of depression, anxiety, fatigue and sleep disturbance in these disorders. References: [1] Cella D, Riley W, Stone a, et al. The Patient-Reported Outcomes Measurement information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol2010;63:1179–94. Disclosure of interests: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 78(2019)Supplement 2
- Issue Display:
- Volume 78, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 78
- Issue:
- 2
- Issue Sort Value:
- 2019-0078-0002-0000
- Page Start:
- 1768
- Page End:
- 1768
- Publication Date:
- 2019-06
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2019-eular.4062 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19925.xml